Last 65.00 NGN
Change Today 0.00 / 0.00%
Volume 7.5K
As of 9:30 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer nig (GLAXOSMI) Snapshot

Open
65.00
Previous Close
65.00
Day High
65.00
Day Low
65.00
52 Week High
02/4/14 - 71.44
52 Week Low
10/3/13 - 62.28
Market Cap
62.2B
Average Volume 10 Days
413.5K
EPS TTM
3.05
Shares Outstanding
956.7M
EX-Date
05/16/14
P/E TM
21.3x
Dividend
1.30
Dividend Yield
2.00%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER NIG (GLAXOSMI)

Related News

No related news articles were found.

glaxosmithkline consumer nig (GLAXOSMI) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer nig (GLAXOSMI) Details

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes consumer healthcare and pharmaceutical products in Nigeria. The company operates in two segments, Consumer Healthcare and Pharmaceuticals. It offers consumer healthcare products, including oral care products, over-the -counter medicines, and nutritional health care products primarily under the Panadol, Andrews Liver salt, Macleans, Sensodyne, Phensic, Lucozade, and Ribena brands; and pharmaceutical products comprising prescription drugs and vaccines principally under the Ampiclox, Amoxil and Augmentin, Zentel, and Halfan brands. The company offers its products for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions, and cancer. The company was formerly known as Beecham Limited. GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971 and is headquartered in Lagos, Nigeria. GlaxoSmithKline Consumer Nigeria Plc is a subsidiary of GlaxoSmithKline Plc.

Founded in 1971

glaxosmithkline consumer nig (GLAXOSMI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

glaxosmithkline consumer nig (GLAXOSMI) Key Developments

GlaxoSmithKline Consumer Nigeria Plc Announces Management Changes

GlaxoSmithKline Consumer Nigeria Plc has announced the appointment of an interim Managing Director, Justin Korteasa following the voluntary resignation of Mr. Chidi Okoro, as the company's Managing Director with effect from March 15, 2014. Until a new candidate is confirmed for the role, the GSK Nigeria Board has appointed Mr. Justin Korte as a Director and the General Manager. Korte joined GSK from Gillette in early 2005, and has progressed through national accounts and national sales roles. After running his own business in 2008, Justin returned to head GSK's Southern Africa business as Group Country Manager. He was promoted in 2011 to Sales Director, Africa.

GlaxoSmithKline To Continue With Its Plan To Acquire Nigerian Unit

GlaxoSmithKline plc (LSE:GSK) may continue with its plans to acquire a majority stake in its Nigerian unit after suspending the plan four months ago. Chidi Okoro, Chief Executive Officer of GlaxoSmithKline Consumer Nigeria Plc (NGSE:GLAXOSMITH), said that the plan by GSK to increase equity in its Nigerian unit was only suspended and will come up later when all parties involved reach an agreement. Chidi said, "Our focus is that if it has to be done, it's done right." GSK, in July 2013, proposed to raise its stake in the Nigerian business to 80% from 46.4%, in a transaction estimated at $98 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLAXOSMI:NL 65.00 NGN 0.00

GLAXOSMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Albany Molecular Research Inc $21.73 USD -0.455
AstraZeneca PLC 4,578 GBp -1.00
Merck & Co Inc $60.46 USD -0.0256
Sumitomo Dainippon Pharma Co Ltd ¥1,428 JPY +20.00
Teva Pharmaceutical Industries Ltd $51.09 USD -1.07
View Industry Companies
 

Industry Analysis

GLAXOSMI

Industry Average

Valuation GLAXOSMI Industry Range
No financial data is available for GLAXOSMI.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER NIG, please visit www.gsk.com/ng. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.